Tech Company Financing Transactions
Mahana Therapeutics Funding Round
On 1/13/2020, Mahana Therapeutics raised $12 million in Seed financing from JAZZ Venture Partners and Lux Capital.
Transaction Overview
Company Name
Announced On
1/13/2020
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Seed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 Market Spear Tower 36th Floor
San Francisco, CA 94105
USA
San Francisco, CA 94105
USA
Phone
Undisclosed
Website
Email Address
Overview
Mahana Therapeutics is a digital therapeutics company. Digital therapeutics are treatment options that use internet- and mobile-based technologies to improve clinical outcomes, quality of life and well-being.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steven Basta
Chief Marketing Officer
Soren Mills
Chief Technical Officer
Simon Levy
VP - Finance
Myla Puyat
VP - Marketing
Kelly Price
VP - Operations
Adam Hardin
VP - Product Management
Ann Montgomery
VP - Regulatory Affairs
Kendal Dinsmore
Browse more venture capital transactions:
Prev: 1/13/2020: New Age Meats venture capital transaction
Next: 1/13/2020: Enlace Health venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. All VC database entries reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs